Takeda Pharmaceuticals USA Inc.: Lisdexamfetamine Dimesylate Capsule shortage reverified (available from this maker)
Takeda Pharmaceuticals USA Inc.: Lisdexamfetamine Dimesylate Capsule shortage reverified (available from this maker). Its amount of 7 is top-decile (91st percentile of 353 records). Dated 2 days ago, it is inside the fresh trigger window. Score 25/100. As of 2026-11-04, from openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list).
Data as of · Compiled by Zalwin from openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list)
amount: 7 · 91th percentile of 353 DrugShortagePulse records · 2.3x the median
Free preview: all 11 published fields of this record are shown below. Locked: 352 related DrugShortagePulse records and the 5-column CSV export.
| Field | Value |
|---|---|
| Manufacturer | Takeda Pharmaceuticals USA Inc. |
| Drug | Lisdexamfetamine Dimesylate Capsule |
| Dosage form | Capsule |
| Therapeutic category | Psychiatry |
| Status | Current |
| Stage | Shortage reverified (still listed) |
| Availability | Available |
| Presentations affected | 7 |
| Package NDCs | 59417-107-10, 59417-104-10, 59417-106-10, 59417-102-10, 59417-103-10, 59417-101-10, 59417-105-10 |
| First posted | 2023-07-14 |
| Updated | 2026-11-02 |
| amount percentile | 91th of 353 (median 3, 2.3x median) |
| Peer records CSV (353 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Takeda Pharmaceuticals USA Inc.
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Free first: a 10-record sample of records
See the real columns before you buy. One confirmation email, nothing else unless you opt in.
Unlock Takeda Pharmaceuticals USA + all 353 records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Manufacturer · Drug · Stage · Availability · Updated · official source URL
- Source agency: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list)
- Record date: 2026-11-02
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top DrugShortagePulse records: Sanofi-Aventis U.S. LLC · Fresenius Kabi USA, LLC · Hospira, Inc., a Pfizer Company · Fresenius Kabi USA, LLC · Hospira, Inc., a Pfizer Company · Browse all by state and category →
LIVE PUBLIC DATA Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list) · Last refreshed: Wed, 04 Nov 2026 06:10:12 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
25 / 100 Score
What is the DrugShortagePulse record for Takeda Pharmaceuticals USA Inc.?
Takeda Pharmaceuticals USA Inc.'s Lisdexamfetamine Dimesylate Capsule is on the FDA drug shortage list. Shortage reverified (still listed); available from this maker. Last updated 2026-11-02.
How does Takeda Pharmaceuticals USA Inc. compare to other DrugShortagePulse records?
This is a top-decile record: its amount of 7 is 2.3x the median of 3 across 353 records. It is fresh: dated 2 days ago, inside the window where early outreach matters most. Its Score of 25/100 is modest; treat it as background rather than a priority.
Takeda Pharmaceuticals USA Inc. vs. top 3 peers
| Organization | Amount | Percentile | Record date |
|---|---|---|---|
| Takeda Pharmaceuticals USA Inc. | 7 | 91st | 2026-11-02 |
| Teva Pharmaceuticals USA, Inc. | 4 | 74th | 2026-11-02 |
| Par Health, USA LLC | 3 | 62nd | 2026-11-02 |
| Gland Pharma Limited | 3 | 62nd | 2026-10-21 |
Related records
DrugShortagePulse: Shortage reverified (still listed) DrugShortagePulse: Psychiatry
How to monitor Takeda Pharmaceuticals USA Inc. and peer psychiatry records
Get new DrugShortagePulse records like Takeda Pharmaceuticals USA Inc. by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new shortages in your categories
DrugShortagePulse emails new and changed FDA drug shortages matching your therapeutic categories.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From the openFDA drug shortages endpoint, which mirrors the FDA drug shortage list and can lag it by days. Availability and recovery notes are the manufacturer's own statements to FDA. Company and product level only. Verify with FDA and the manufacturer before acting.